Evidence map›Paper›PMID 35739402›Full record

ArticleCellular and molecular life sciences : CMLS2022

Bidirectional regulation of synaptic SUMOylation by Group 1 metabotropic glutamate receptors.

Marie Pronot, Gwénola Poupon, Lara Pizzamiglio, Marta Prieto, Isabel Chato-Astrain, Iliona Lacagne, Lenka Schorova, Alessandra Folci, Frédéric Brau, Stéphane Martin

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Marie PronotUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Gwénola PouponUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Lara PizzamiglioUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Marta PrietoUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Isabel Chato-AstrainUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Iliona LacagneUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Lenka SchorovaUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Alessandra FolciUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Frédéric BrauUniversité Côte d'Azur, CNRS, IPMC, Valbonne, France.
Stéphane MartinUniversité Côte d'Azur, INSERM, CNRS, IPMC, Valbonne, France. martin@ipmc.cnrs.fr.ORCID http://orcid.org/0000-0001-6771-7645
Centre National de la Recherche Scientifique · FR

Funding

Agence Nationale de la Recherche ANR-11-LABX-0028-01Agence Nationale de la Recherche ANR-15-IDEX-01Agence Nationale de la Recherche ANR-20-CE16-0006-01Fondation pour la Recherche Médicale #FDT202012010480
6 · The paper itself

Abstract

SUMOylation is a post-translational modification essential to cell homeostasis. A tightly controlled equilibrium between SUMOylation and deSUMOylation processes is also critical to the neuronal function including neurotransmitter release and synaptic transmission and plasticity. Disruption of the SUMOylation homeostasis in neurons is associated with several neurological disorders. The balance between the SUMOylation and deSUMOylation of substrate proteins is maintained by a group of deSUMOylation enzymes called SENPs. We previously showed that the activation of type 5 metabotropic glutamate receptors (mGlu5R) first triggers a rapid increase in synaptic SUMOylation and then upon the sustained activation of these receptors, the deSUMOylase activity of SENP1 allows the increased synaptic SUMOylation to get back to basal levels. Here, we combined the use of pharmacological tools with subcellular fractionation and live-cell imaging of individual hippocampal dendritic spines to demonstrate that the synaptic accumulation of the deSUMOylation enzyme SENP1 is bidirectionally controlled by the activation of type 1 mGlu1 and mGlu5 receptors. Indeed, the pharmacological blockade of mGlu1R activation during type 1 mGluR stimulation leads to a faster and greater accumulation of SENP1 at synapses indicating that mGlu1R acts as a brake to the mGlu5R-dependent deSUMOylation process at the post-synapse. Altogether, our findings reveal that type 1 mGluRs work in opposition to dynamically tune the homeostasis of SUMOylation at the mammalian synapse.

Indexed as

Receptors, Metabotropic GlutamateSumoylationAnimalsHippocampusMammalsNeuronsSynapsesReceptors, Metabotropic GlutamateCaMKIIdeSUMOylationmGlu1mGlu5 receptorsPKCSENP1SUMOSynapse

Identifiers

PMID35739402
PMCPMC9226087
OpenAlexW4283320017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.